 REDWOOD CITY, Calif.--BUSINESS WIRE--Please replace the release dated May 19, 2021 with the following corrected version due to a change in the fourth paragraph. The updated release reads: GUARDANT HEALTH PRESENTS DATA AT 2021 ASCO ANNUAL MEETING SHOWING UTILITY OF LIQUID BIOPSY IN EARLY- AND LATE-STAGE CANCERS Data from 20 abstracts demonstrate value of companys blood tests across the continuum of cancer care, including: screening, therapy selection, residual and recurrent disease detection, 